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Pulmonary Toxicity of Thioureas in the Rat
by Angus M. Scott,* Gillian M. PoweII,* David G. Upshall,t
and C. Gerald Curtis*
Administration ofa-naphthylthiourea(ANTU)toratscausesdamagetopulmonaryendothelialcells
and possibly mesothelial lining ceils that together may account for the massive pleural effusion
characteristic ofthiourea toxicity. Using 35S-thiourea as a model compound, the extent ofbinding of
35S to lungproteins correlatedweli withthe extent ofedema, suggestingthatthe extent ofbinding of
thiourea metabolites is a measure oflung toxicity. ANTU and phenylthiourea (PTU) compete for 35S
bindingtolungslices, suggestingthatthesetoxinsmayactinasimilarway. Bindingof35Sinlungslices
from resistant rats is much less than in controls, and resistance cannot be explained by differences
ineitherwholebodymetabolism orredistributionofthioureain vivo. Lungglutathionelevels (invitro
and in vivo) innormalandresistant ratsfoliowingthioureaadministration wereessentiallythe same.
However, atdosesofthioureathatcausepleuraleffusion,therewasanincreaseintotallungglutathione.
Introduction
The thioureas cause massive pulmonary edema and
pleural effusion in rats (1-4). One of them, ci-napthyl-
thiourea (ANTU) was developed as a rat poison, but
during extensive trials (4) it became apparent that rats
ingestingsmallnonlethaldosesofANTUrapidlybecame
resistant to it (tachyphylaxis). This resistance reduced
the effectiveness of such compounds as potential
rodenticides but nevertheless provided a useful model
to investigate their mode(s) of action.
Ultrastructural studies have shown high specificity
of thioureas for pulmonary endothelial cells (5,6), and
even at high doses (50 mg/kg) there appears to be little
damage to anyothercellsinthealveolarcapillary unit,
although the edema may be extensive (6). In addition,
ANTU-induced biochemical changes in levels ofangio-
tensin converting enzyme (7-9) and 5-hydroxytrypta-
mine uptake (10) are considered to reflect specific
endothelial cell damage.
Massive pleural effusion is a characteristic feature
of thiourea toxicity. It ispossible that the intrathoracic
pressure exerted on the lung by this effusate is often
the causeofdeath, ratherthanthealveolaredemathat
also occurs. Despite extensive research, the mode of
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action of these compounds remains unclear, although
there is good evidence to suggest that the thioureas
require metabolic activation before toxic effects are
manifested (11-16). Although the mechanism of ac-
tivation has not been resolved, thiols protect against
thiourea toxicity and covalent binding (17), and
glutathione depletion enhances both the toxicity and
proteinbindingofANTU(11)andthiourea(15). Further,
administration of either glutathione or cysteine pro-
tects against the toxicity of phenylthiourea (PTU) in
vivo (18). It has also been shown that glutathione can
protect against the binding of radioactivity in studies
with 14C-thiourea in vitro (15). Binding studies with
14C-thiourea (13-17) have demonstrated the covalent
binding of radiolabel to proteins in lung and liver, and
that binding is less in resistant rats. It has also been
shown thatradiolabeledANTU bindscovalentlytopro-
teininthelungandliver(11,12). Interestingly, between
two and six times the binding is observed if ANTU is
labeled with 35S ratherthan 14C (11,12), which suggests
thatbinding of 35S is a better measure oftotalbinding.
No binding studies, however, have been undertaken
with 35S-thiourea.
In this study, three aspects of thiourea toxicity are
explored: namely a) the effect of ANTU on the ultra-
structure of the rat lung with particular attention
focused on the mesothelial layer that lines the surface
of the lung, b) the binding of 35S (from 35S-thiourea) to
tissue proteins in vivo and in vitro in normal and
thiourea-resistantratstodetermineifthereisacorrela-SCOlTETAL.
tion between toxicity and binding, and c) the levels of
glutathione in lungs of normal and resistant rats.
Materials and Methods
Chemicals
All chemicals used were Analar grade unless stated
otherwise. a-Naphthylthiourea was a gift from the
Chemical Defence Establishment (Porton Down, Salis-
bury, UK).
Radiochemicals
35S-Thiourea(25 or60mCi/mmole) wasobtainedfrom
Amersham International (Bucks, UK).
Experimental Animals
MRC hooded rats (300-400 g) were used throughout
the study and were fed on diet 41B (Pilsbury Ltd.,
Edgbaston, Birmingham, UK).
Development of Thiourea Resistance
Animals received 0.5 mg of thiourea/kg body weight
insaline(0.15M, 0.3 mL)IPdailyfor3days. Control rats
were injected with saline (0.15 M) alone. Treated rats
weredesignated resistant; control weredesignated nor-
mal. Experiments were carried out24 to48 hrafterthe
final injection.
Electron Microscopy
Rats, underetheranesthesia, receivedpentobarbitone
(60mg/kg)IVviathepenalvein. Thetracheawasisolated
and cannulated (Portex, Hythe, Kent, UK; int. dia. 1.67
mm; ext. dia. 2.42 mm). After amidlineabdominalinci-
sion, a small incision was made in the diaphragm to
deflate the lungs. The thoracic cavity was exposed and
the lungs were fixed by the method of Hammond and
Mobbs(19). Formalin vapor wasinstilled viathetrachea
cannula until the lungs were fully inflated. The lungs
were removed, thetrachea wasclamped, andthewhole
preparation was immersed in phosphate-buffered for-
malin(pH 7.4)for72 hr. Blocksoftissue(approximately
1 mm3) were cut from two areas of the lung-from the
edge containing the mesothelial layer and from central
areas of lung parenchymal tissue. These blocks were
stained with uranyl acetate (2%) for 60 min in the dark
at4°C, anddehydrated inethanolfollowedbypropylene
oxide, and embedded in araldite. Sections (60-90 nm)
werecutusing aReichartOM4microtome andmounted
on acelloidine-carbon coatedgrid. Sections werestain-
ed in 5% uranyl acetate followed by Reynold's lead
citrate. Sections were examined in a Philips EM 400T
electron microscope at 80 KV acceleration voltage.
Preparation of Lung Slices
Animals were anesthetized as described above and
exsanguinated. Thelungs weredeflatedandthethoracic
cavity was exposed. An incision was made in the right
ventricle of the heart and a cannula (Portex; int. dia.
1.67 mm; ext. dia. 2.42 mm) was inserted into the
pulmonaryartery. Isotonicsalinewasperfusedintothe
lung at a pressure of 25 cm H20, and an incision made
in left auricle allowed the exit ofsaline from the lungs.
Thisprocedureclearedthevascularbed. Followingper-
fusion, the lungs were dissected free from the heart,
esophagus, andassociatedconnectivetissue. Theexter-
nal surfaces of the lungs were rinsed in ice-cold saline
(0.15 M NaCl). Slices(0.7 mm) were prepared usingthe
MclllwaintissuechopperandincubatedinMEMEagles
medium(200mgtissue/mLmedium)inashakingwater
bath(37OC)with continuousgassing(95% 02, 5% CO2).
Slices were equilibriated for 30 min and then suspend-
ed in fresh medium.
Preparation of Tissues for Binding
Studies (In Vivo)
Animalswereanesthesizedwithether, andpentobar-
bitone(60mg/kg)wasadministeredIVviathepenalvein.
Following a midline abdominal incision, the dorsal
aorta was isolated and clamped distal to the renal
artery. Acannula(int. dia. 1.67 mm; ext. dia. 2.42 mm)
wasinsertedintothedorsalaortaandsaline(0.15MNaCl)
was infused via the cannula at a pressure of 1 M H20.
An incision was made in the vena cava immediately
anteriorto the diaphragm to allow the saline to escape.
This procedure cleared the liver and kidneys of blood.
Thelungswere alsoperfusedfree ofbloodasdescribed
previously. Lungs, liver, and kidneys were removed,
weighed, and assayed for protein-bound radioactivity.
Assay for Protein-Bound 35S
Tissue homogenates (20%) were prepared in ice-cold
saline (0.15 M NaCl). Five volumes of ice-cold trichlo-
racetic acid (TCA) (20% w/v) containing phospho-
tungstic acid (2% w/v) were added to one volume of
tissuehomogenate, the sampleswere kept on ice for30
minandcentrifuged(600g, 5min). Thesupernatantwas
discardedandthepelletresuspended infivevolumesof
ICA (20%). This step was repeated three times or until
radioactivitywasnotdetectableinthesupernatants. The
washedpelletwasthendissolvedin2.5MNaOHat60(C
for 4 hr. Protein in the solubilized pellet was deter-
mined by the method of Lowry et al. (20). Radioactiv-
ity was determined by scintillation counting (LKB
Rackbeta 1217) with quench curve correction by the
external standard ratio method.
Measurement of Glutathione
Tissue homogenates (3% w/v) were prepared in ice-
cold EDTA (30,M). Aliquots (1 mL) were filtered using
Centricon 10Kfilters(Amicon)bycentrifuging(600gfor
30 min at40C). The filtrates were diluted 10 timeswith
EDTA (30 AM) and assayed for glutathione by the o-
phthalaldehyde fluorometric assay(21) usingaHitachi-
PerkinElmerMPF-2A fluorescencespectrophotometer.
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Actual amounts of glutathione were determined using
a standard curve.
Experimental and Results
Effect of ANTU on Lung Ultrastructure
Three rats received a single IPinjection ofANTU (20
mg/kgbody weight) dispersed in olive oil(0.3 mL), and
three rats (designated control) received olive oil alone.
Electronmicrographsofthealveolarcapillaryunitfrom
controls (Fig. 1A) showed no edema in the alveolar
spaces. Moreover,TyrpeIepithelialcells, capillaryendoth-
elial cells, andthebasementmembraneallappearedin-
tact. Bycontrast, themicrographobtained fromANTU-
treated lungsisshowninFigure 1B. The alveolar space
isfloodedwithfluidandprotein, andtheendothelialbar-
rier appears absent, whereas the basement membrane
and ¶Iype I cells appear intact and unaffected. In addi-
tion, changes wereobservedinthemesothelialcelllayer
that linesthe outside ofthe lung. A normalmesothelial
celllayerfrom acontrolanimalinwhichtwomesothelial
cells lie on athinbasement membrane, overlyinginter-
stitial tissue containing collagen bundles is shown in
Fig. 2A. After ANTU challenge (Fig. 2B) thejunctions
between the cells appear intact; the underlying base-
ment membrane, however, is grossly swollen.
Binding of 35S (from Thiourea) to
Proteins in Lung, Liver, and Kidneys
In Vivo
Resistant and normal rats (three of each) were
anesthetized with ether and received 35S-thiourea (15
mg/kgbodyweight, 7ACi/mmole)in0.15MNaCl(0.3 mL)
IP. After 4 hr the animals were anesthetized and the
vascular beds of liver, lungs, and kidneys were cleared
ofblood. Eachtissue wasassayedforprotein-bound35S.
In normal rats, protein binding was highest in lung;
however, binding was approximately 60% less in resis-
tantrats(Fig. 3). Inthisstudyresistance wasdeveloped
byrepeatedadministration oflow dosesofnonradioac-
tive thiourea. It was, therefore, possible that unlabeled
drug was occupying binding sites in the tissues of the
resistant rats. The subsequent binding of 35S thiourea
would then show an apparent decrease because some
of the binding sites were already occupied. To elimi-
nate this possibility, resistance was developed using
35S-thiourea. Rats were treated with 35S-thiourea (0.5
mg/kg body weight, 5 ACi/mmole) IP daily for 3 days;
24 hr after the final injection the vascular beds of the
lungs, liver, and kidneys were cleared of blood and
protein-bound 35S was measured. Ibtal binding of 35S
under these conditions was relatively low (approxi-
mately 0.2% ofthat observed in normal rats after 4 hr
at adoseof 15mg/kgbodyweightwhich causesedema);
therefore, the reduced binding in resistant rats could
not beexplained bythesaturationofbindingsiteswith
thiourea orits metabolites. Inthese in vivostudies, the
degreeofresistancewasconfirmedbyusingtheratioof
wet weight lung/body weight as an index of edema
following thiourea challenge. Resistant rats showed
consistently lessedemathanthenormals, andtherewas
a good correlation (correlation coefficient 0.963)
between the amount of protein-bound 35S in lung and
the degree of edema (Fig. 4).
Binding of 35S (from Thiourea) to
Proteins in Lung Slices
Lungslicesfromtwononnalratsandtworesistantrats
werepreparedasdescribed. Sliceswereincubatedwith
35S-thiourea(0.167 mM, 6IACi/mmole)for 2 hr. Protein-
bound35Swasapproximately65% lessinresistantslices
than inthe normals(Thble 1). EquimolarANTU orPTU
inhibited binding in normal slices by 76% and 69%,
respectively, whereas urea ( the oxygen analogue of
thioureathatdoesnotproduceedema)hadnoeffecton
thebindingof35S.ANTUandPTUalsoreducedthebind-
ing in slices from resistant animals by 44% and 38%,
respectively, whereas urea had no effect.
Effect of Thiourea on Lung
Glutathione Levels
RatsreceivedIPinjectionsofthiourea(15mg/kgbody
weight; in0.15MNaCl, 0.3mL) or0.15MNaCl(0.3mL).
At 1 and 2 hr after administration animals were
anesthetized, thelungsclearedofblood, and thetissue
was assayed for glutathione. Glutathione levels in test
and control lungs were the same after 1 hr, but after
2 hr the glutathione levels inthioureatreated rats had
risen by 60% (lible 2).
Ibble 1. The in vitro binding of35S derived from 3'S-thiourea
to protein in lung slices.'
Protein binding,
pmole 35S-thiourea equivalents/mg protein
Incubation conditions Normal slices Resistant slices
Thiourea 217 ± 35 75 ± 5
Thiourea + ANTU 53 3 42 1
Thiourea + PTU 68 + 15 47 + 5
Thiourea + urea 243 ± 72 82 ± 9
an = 3. Values are ± SD.
Table 2. Lung glutathione levels following thiourea
challenge (15 mg/kg body weight) in vivo.a
Time, nmole GSH/whole lung Lung wet weight, g
hr Control Test Control Test
1 311 7 322 46 1.39 0.03 1.59 +
0.26
2 452 ±30 764 7 1.42 ±0.04 3.85 +
0.65
an = 2; see text for experimental details.
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FI(;GURE 1. (A) Electron micrograph of a typical normal alveolar capillary unit, xlO,000. (B) Electron micrograph of a typical alveolar
capillary unit following ANTU challenge (20 mg/kg), xlO,000. Abbreviations: en, endothelial cell; alv, alveolus; I, 'Iype I epithelial
cell; o, edematous protein; *, endothelial cell not present.PULMONARY 7OXICITYOF THIOUREAS IN THERAT
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FIGURE 2. (A) Electron micrograph of a typical normal mesothelial lining layer, x10,000. (B) Electron micrograph of a typical mesothelial
lininglayerfollowing ANTUchallenge(20 mg/kgbody wt), x10,000. Abbreviations: cyt, cytoplasm; bm, basement membrane; c, collagen
bundles; and II, Type II epithelial cell.
Inotherexperiments, lungsliceswereprepared from
normal and resistant rats and incubated in vitro in the
presence andabsence of 1 mMthiourea. Thetissue was
sampled at 0, 1, and 2 hr and assayed for glutathione.
Glutathionelevelsweresubstantiallythesameinnormal
and resistant rats at all of the time points (Fig. 5).
In further experiments glutathione levels were
measured inlungsfrom normaland resistant rats 24 hr
followingthefinalinjection. Levelsofglutathione were
not altered significantly in resistant rats (normal: 428
±15 nmole GSH/whole lung; resistant: 460 +18 nmole
GSH/wholelung. Resultsexpressed asanaverageoftwo
determinations).
Discussion
Many edemagenic agents are reported to cause pul-
monaryendothelialdamage, allowingexcessivefluidto
invadetheinterstitium. Therearethreepossible routes
forthesubsequentescapeofthefluid: clearancebylym-
phatics, passage into the alveolar airways, and passage
into the pleural cavity. The majority of edemagenic
agentsenhancethepassageoffluidintoalveolarairways,
presumablybycausingdamagetothealveolarepithelial
lining, resultinginalveolaredema. However, thethiour-
eas are unusual in causing severe pleural effusion,
possibly because of an apparent sensitivity of the
mesothelialcelllininglayer. Thispossibilityissupported
bytheresultsreportedhere. Evidenceisalsopresented
thattheextentofbindingoftheagentoritsmetabolites
isrelated to edemaformationandthatthioureasdonot
cause depletion ofglutathione levels. Resistance to the
toxins cannot be explained by differential metabolism,
tissue distribution, or altered glutathione levels.
SDS-PAGE analysis ofthe protein composition ofthe
pleural effusion following ANTU induced lung damage
has shown that it is qualitatively identical to that of
normalplasma(unpublishedobservations). Thepassage
ofthiscell-freefiltrateintothecavitymightbeexpected
to coincide with pulmonary vascular endothelial
damage, and this is confirmed by ultrastructural and
histochemical examinations in this and other studies
with thioureas (5-10). Whether or not endothelial
damagealoneissufficienttoallowexcessivemovement
offluidintothepleuralcavityisnotclear. However, the
associated change in the mesothelial basement mem-
brane (grossly swollen) and the lack of any apparent
changes to the alveolar epithelial barrier suggests that
these particular bloodborne edemagenic agents are
atypical in causing pleural effusion as well as alveolar
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FIGURE 3. The binding in vivo of 35S derived from 35S-thiourea to
protein in lung, liver, and kidney. Open bars represent three normal
rats challenged with 35S-thiourea (15 mg/kg). Single hatched bars
representthreeresistantratschallenged with35S-thiourea(15mg/kg).
Closed bars represent binding that occurs during the induction of
resistance(threedosed at0.5mg/kgfor3days). Errorbarsrepresent
standard deviation.
edema. Inspiteoftheincreasedvesicularactivityinthe
mesothelial cells, thiseffectofthioureas maynotbedue
entirelytodirectactionofthetoxinbutanormaldefense
response to the presence of excess fluid in the pleural
cavity.
Metabolismandbindingstudieswith14C-thioureasug-
gested the needformetabolic activation ofthetoxinto
a reactive metabolite that alkylates tissue proteins
(13-17). The present studies demonstrate that protein
binding of35S derived from 35S-thiourea is very closely
correlatedwithtoxicity. Furthermore, importantly, they
demonstratethatinresistantanimalsthereis adramatic
reduction inbound35S. It ispossible, therefore, that 35S
binding is a direct measure oftoxicity and that the ac-
tive metabolites alkylate tissue proteins causing the
pulmonary edema that is typical of thiourea toxicity.
The identity ofthe active metabolite(s) ofthiourea is
unknown, but it hasbeensuggested thatANTU canbe
activated to atomic sulphur(12). That asimilar mecha-
nism may operate for thiourea is supported by the in-
hibitory effects ofANTU and PTU on 35S binding from
2 I
Wetwt/Bodywt(xlO2)
FIGURE 4. Correlation between pulmonary edema (expressed as
lung wet wt/body wt ratio) and in vivo binding of 35S derived
from 35S-thiourea (15 mg/kg body wt, IP) to lung protein; (A),
normal rats; (A), resistant rats. Correlation coefficient = 0.963.
(For experimental details see text.)
35S-thiourea in vitro. The binding of 35S from thiourea
to lung proteins in vitro and the decreased binding in
lung slices from resistant rats suggests that activation
takes place in the lung and that activated metabolites
produced in the liver are not transported in the blood
as, for example, pyrrolizidine alkaloids (22).
The number of proteins/enzymes reacting with
metabolites of thioureas has yet to be established,
although it is knownthatANTU decreasesthe activity
of cytochrome P-450 in lung and liver in vitro (11,12).
However, activationofthioureasmayalsooccurbynon-
microsomal enzymes because in lungs exposed to
'4C-thiourea in vivo, 75% oftotal 14C bound to protein
occurs in the supernatant fraction (13,14).
The mechanism(s)by which ratsbecome resistant to
thioureasfollowingtheadministrationofsmallnonlethal
doses is intriguing. Unpublished work from these
laboratories has shown that in anesthetized rats (with
uretercannula)there isnosignificantdifferenceinthe
metabolismandrateofexcretionof35S-thioureabetween
normalandresistantrats. Moreover, thedifferentialbind-
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ingto lungproteins in vitro from normal and resistant
rats also suggests that resistance is afforded by
biochemicalalterationsinlungitselfandnotbychanges
in the disposition of thiourea in vivo.
ANTUandPTU, whichareedemagenicagentsintheir
ownright, competewith35S-thioureaforbindinginvitro,
suggestingthattheyactbythe same pathway(Table 1).
Interestingly, ANTUandPTUcompetedlesswellforthe
binding in resistant lung slices; this might suggest the
presence oftwotypesofbindingsite, anonspecific site
present in both normal and resistant lung slices, and a
specificsite(s)thatisreducedormasked inresistantrats.
Thesefindingsareinkeepingwiththetwotypesofbind-
ingsitesobservedforH4C-thiourea(15). Thefactthaturea
does not compete for binding suggests that the C = S
moiety is required for binding and toxicity.
Hollinger et al. (17) have reported that thiourea can
depletetissueglutathione byasmuchas90% after 1 hr,
andthesedataareconsistentwiththeobservationsthat
depletionoftissueglutathionewithdiethylmalateleads
toincreased toxicityofthioureas, whereascoadministra-
tion with thiols prevents edema (18). It was surprising,
therefore, that in the present study there was no evi-
dence to suggest that thiourea is able to deplete lung
glutathionelevelsinvivo. Indeed, at2 hrafterthiourea
treatment, lungglutathionelevelswereincreasedbyap-
proximately 60%, at which point lung wet weight had
increasedbyapproximately 100%. Theapparentdiffer-
encebetweentheseresultsandthoseofHollingeretal.
(17)maybeexplainedbythedifferentassaysystemsfor
glutathione. Hollingeretal. employedtheassaydescrib-
edbyEllman(23)thatisnonspecificandmeasurestotal
thiol. Inthislaboratoryafluorometricassayspecificfor
glutathione wasused(21). Inadditionitwasshownthat
thiourea does not interfere with the latter assay, even
whenina 10,000-fold excess(unpublishedobservations).
Thus, in this study using a more specific assay for glu-
tathione, there was no evidence to suggest thatthe ap-
pearance of edema coincided with a decrease in total
glutathione levels in lung. Moreover, the induction of
resistance cannot be explained by an increase in total
lung glutathione because levels were not elevated in
resistant rats.
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